Production (Stage)
Cardio Diagnostics Holdings, Inc.
CDIO
$4.15
-$0.14-3.26%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -39.51% | 105.29% | 181.10% | 1,348.15% | 3,190.00% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -39.51% | 105.29% | 181.10% | 1,348.15% | 3,190.00% |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -39.51% | 105.29% | 181.10% | 1,348.15% | 3,190.00% |
SG&A Expenses | -40.08% | 17.71% | 5.98% | 9.76% | 64.05% |
Depreciation & Amortization | 214.06% | 2.60% | 4.35% | 9.09% | 14.29% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -39.79% | 15.72% | 4.15% | 8.70% | 61.63% |
Operating Income | 39.79% | -15.51% | -3.87% | -8.24% | -61.11% |
Income Before Tax | 49.12% | -0.08% | 11.88% | -2.19% | -112.97% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 49.12% | -0.08% | 11.88% | -2.19% | -112.97% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 49.12% | -0.08% | 11.88% | -2.19% | -112.97% |
EBIT | 39.79% | -15.51% | -3.87% | -8.24% | -61.11% |
EBITDA | 42.85% | -13.44% | -1.41% | -5.76% | -59.31% |
EPS Basic | 77.52% | 52.35% | 57.81% | 47.03% | -20.14% |
Normalized Basic EPS | 77.44% | 52.17% | 53.93% | 41.22% | -21.54% |
EPS Diluted | 77.52% | 52.35% | 57.81% | 47.03% | -20.14% |
Normalized Diluted EPS | 77.44% | 52.17% | 53.93% | 41.22% | -21.54% |
Average Basic Shares Outstanding | 120.19% | 112.09% | 111.49% | 107.72% | 100.12% |
Average Diluted Shares Outstanding | 120.19% | 112.09% | 111.49% | 107.72% | 100.12% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |